Diagnosis of MEN syndromes involves careful screening of patients with endocrine tumours. Diagnostic suspicion is raised if numerous symptoms are present. Diagnosis of MEN1 is based on patients having 2 or more MEN1-associated tumours, or 1 associated tumour and a first-degree relative with the condition, or on the basis of genetics alone with a diagnosed pathogenic mutation of MEN1.[1]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer